Search Results
Search results for "Shane Wright"
Results found for "Shane Wright"
- Amgen to Acquire Chemocentryx for $4 Billion in Cash
companies have entered into a definitive agreement under which Amgen will acquire ChemoCentryx for $52 per share
- Dr. GPCR and Celtarys Research Join Forces to Expand Access to Innovative GPCR Tools
GPCR allows us to engage with researchers worldwide who are shaping the future of receptor-targeted therapies
- Dr. GPCR and Eurofins DiscoverX Join Forces to Accelerate GPCR Drug Discovery
“Through this collaboration, we look forward to sharing scientific insight, best practices, and real-world
- đź“° GPCR Weekly News, April 1 to 7, 2024
We're excited to share our coverage of the latest developments in GPCRs for this week. We also ask that you share this with your eligible colleagues.
- Production of human A2AAR in lipid nanodiscs for 19F-NMR and single-molecule fluorescence...
We explain in detail steps shared between the two sample preparation strategies, including expression
- Structural dynamics of Smoothened (SMO) in ciliary membrane and its interaction with membrane lipids
in the ciliary membrane, and to gain molecular-level insights into the role of the primary cilia in shaping reveals the movements of TM5, TM6, and TM7, linked with the helix8, which are possibly involved in shaping
- Allosteric Binding Data Interpretation in Complex Receptor Systems
inverse sigmoidal displacement curve—long treated as a signature of competitive interaction—retains its shape This distinction has direct implications: Curve shape alone cannot diagnose mechanism Rightward shifts
- Job Opportunity Spotlight #1: Principal Scientist, In Vitro Pharmacology
Our conversation provided additional insight you cannot find in a job description, so I thought I’d share
- Production of human A2AAR in lipid nanodiscs for 19F-NMR and single-molecule fluorescence...
We explain in detail steps shared between the two sample preparation strategies, including expression
- đź“° GPCR Weekly News - January 2 to 8, 2023
Hello Readersđź‘‹, We're excited to share our weekly newsletter with you. Sherwin Sells 30,000 Shares STALICLA signs agreement with Novartis on neurodevelopmental disorders Call
- Dr. GPCR Spotlights Revvity’s pHSense™ Internalization Tools
GPCR Podcast , where he shares the story behind pHSense , including its application in real-time internalization
- The Dr. GPCR Happy Hour Returns to Boston: September 30
A smaller gathering is the difference between meeting three people you'll actually remember and shaking
- Dr. Nicola J. Smith - Dr. GPCR Podcast
Please share! https://www.ecosystem.drgpcr.com/dr-gpcr-podcast/ #gpcr #drgpcr #podcast
- GPCR Pharmacology Insights That Prevent Real Drug Discovery Failures
Allosteric modulators interact with the system already in motion, shaping the receptor’s behavior without GPCR innovation is accelerating, and those who invest in deeper GPCR pharmacology insights today will shape
- AlphaFold2 versus experimental structures: evaluation on G protein-coupled receptors
different in many aspects including the assembly of the extracellular and transmembrane domains, the shape
- Profiling Immune Cell and Platelet Transcriptomes
As the field continues to evolve, the insights gained from this research will be instrumental in shaping
- The Real Cost of Strategic Overload in Biotech
indications are progressing, a grant application is underway, and early partnership conversations are taking shape And diluted commitment quietly shapes investor perception long before the first pitch meeting ever takes
- Embark on a GPCR Adventure: Your Weekly Research Expedition! | Oct 21-27, 2024
Let’s keep fostering a collaborative environment for sharing ideas and expanding knowledge!
- đź“° GPCR Weekly News, February 5 to 11, 2024
We will also have a poster session in breakout rooms on Zoom; if you are interested in sharing your work You'll share your contributor articles with the community, stay updated with GPCR literature, network
- đź“° GPCR Weekly News, May 27 to June 2, 2024
More details will be shared soon, and registration will open in July 2024. Dr. Join the global GPCR community to share your research—submit your abstract using this form.
- đź“° GPCR Weekly News, July 24 to July 30, 2023
Want to share your work in an informal setting? We'll be sharing the list of our confirmed speakers soon!
- Multifunctional role of GPCR signaling in epithelial tube formation
formation requires Rho1-dependent actomyosin contractility to generate the cellular forces that drive cell shape
- GPCRs steer G i and G s selectivity via TM5-TM6 switches as revealed by structures of serotonin...
We find that the macro-switch by the TM5-TM6 length is shared by class A GPCR-G protein structures.
- TM5-TM6: structural switches that modulate the coupling of serotonin receptors to Gs or Gi
Prior to this report we did not know how different serotonin receptor subtypes which share high sequence Interestingly, in the case of promiscuous receptors they found that these receptors shared conserved
- Dr. JoAnn Trejo - Dr. GPCR Podcast
Sharing how she became a scientist, educator, mentor, and the powerhouse we know today.
- Multifunctional role of GPCR signaling in epithelial tube formation
formation requires Rho1-dependent actomyosin contractility to generate the cellular forces that drive cell shape
- đź“° GPCR Weekly News, February 12 to 18, 2024
We will also have a poster session in breakout rooms on Zoom; if you are interested in sharing your work You'll share your contributor articles with the community, stay updated with GPCR literature, join a
- đź“° GPCR Weekly News, January 22 to 28, 2024
Please email us at Hello@DrGPCR.com if you want to share your work with our community. GPCR University We're thrilled to share that all spots for the Applying Pharmacology to Drug Discovery
- AlphaFold’s Breakthrough in GPCR Research: Revolutionizing Discovery, Yet Awaiting Experimental Proof
The AlphaFold-predicted models revealed distinct ligand-binding site shapes, enabling the prioritization
- GPCR Happy Hour – Boston, Sept 2025
chance to stand shoulder-to-shoulder with peers from across the globe and the Boston biotech scene, to share











